Affiliation:
1. School of Chemistry and Chemical Engineering Harbin Institute of Technology Harbin Heilongjiang 150001 China
2. Hainan Mengniu Technology Development Co., Ltd. Haikou Hainan 571900 China
3. School of Food Science and Engineering Inner Mongolia Agricultural University Hohhot Inner Mongolia 010018 China
Abstract
ScopeDietary intervention has emerged as a promising strategy for the management of nonalcoholic fatty liver disease (NAFLD). The aim of this study is to investigate the ameliorative effects of the α‐lactalbumin peptide Asp‐Gln‐Trp (DQW) against NAFLD and the underlying mechanism.Methods and resultsThe models of lipid metabolism disorders are established both in HepG2 cells and in C57BL/6J mice. The results demonstrate that DQW activates peroxisome proliferator‐activated receptor α (PPARα) and subsequently ameliorates lipid deposition and oxidative stress in vitro. Interestingly, GW6471 markedly attenuates the modulatory effects of DQW on the PPARα pathway in HepG2 cells. Moreover, results of in vivo experiments indicate that DQW alleviates body weight gain, dyslipidemia, hepatic steatosis, and oxidative stress in high‐fat‐diet (HFD)‐induced NAFLD mice. At the molecular level, DQW activates PPARα, subsequently enhances fatty acid β‐oxidation, and reduces lipogenesis, thereby ameliorating hepatic steatosis. Meanwhile, DQW may ameliorate liver injury and oxidative stress via activating the PPARα/nuclear‐factor erythroid 2 (Nrf2)/heme‐oxygenase 1 (HO‐1) pathway.ConclusionThose results indicate that α‐lactalbumin peptide DQW may be an effective dietary supplement for alleviating NAFLD by alleviating lipid deposition and oxidative stress.
Subject
Food Science,Biotechnology
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献